Immunic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.

About IMUX

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. 

CEO
Daniel Vitt
CEODaniel Vitt
Employees
77
Employees77
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2003
Founded2003
Employees
77
Employees77

IMUX Key Statistics

Market cap
119.52M
Market cap119.52M
Price-Earnings ratio
-0.62
Price-Earnings ratio-0.62
Dividend yield
Dividend yield
Average volume
758.18K
Average volume758.18K
High today
$1.36
High today$1.36
Low today
$1.26
Low today$1.26
Open price
$1.32
Open price$1.32
Volume
461.79K
Volume461.79K
52 Week high
$3.11
52 Week high$3.11
52 Week low
$0.9451
52 Week low$0.9451
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.